Inventor · name-matched record
SAHIN UGUR
7 granted patents·5 pending applications·80 citations·filing 1996–2025
77Inventor score
Files withBioNTech SE5BIONTECH CELL & GENE THERAPIES GMBH3ASTELLAS PHARMA INC1BIONTECH RNA PHARMACEUTICALS GMBH1CORNELL RES FOUNDATION INC1
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
12 records- 0192US5804381AIsolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereofCORNELL RES FOUNDATION INC·Filed 1996·Granted Sep 8, 1998·80 cites·8 claims
- 0289US2026085126A1Agonistic tnf receptor binding agentsBioNTech SE·Filed 2025·Application pending·0 cites
- 0387US2026069687A1Therapy involving antibodies against claudin 18.2 for treatment of cancerASTELLAS PHARMA INC·Filed 2025·Application pending·0 cites
- 0486US2026049112A1Tumor Antigens for Determining Cancer TherapyBioNTech SE·Filed 2025·Application pending·0 cites
- 0578US2026091060A1Antigen receptors and uses thereofBIONTECH CELL & GENE THERAPIES GMBH·Filed 2024·Application pending·0 cites
- 0673US12559531B2Claudin-6-specific immunoreceptors and T cell epitopesBIONTECH CELL & GENE THERAPIES GMBH·Filed 2022·Granted Feb 24, 2026·0 cites·7 claims
- 0772US12570751B2Binding agents binding to PD-L1 and CD137 and use thereofGENMAB AS·Filed 2021·Granted Mar 10, 2026·0 cites·46 claims
- 0870US12516333B23′-UTR sequences for stabilization of RNABioNTech SE·Filed 2022·Granted Jan 6, 2026·0 cites·20 claims
- 0968US12516104B2Compositions and methods for diagnosis and treatment of cancerBioNTech SE·Filed 2023·Granted Jan 6, 2026·0 cites·13 claims
- 1063US2026048110A1Rna for preventing or treating tuberculosisBioNTech SE·Filed 2023·Application pending·0 cites
- 1148US12522640B2IL2 agonistsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Jan 13, 2026·0 cites·25 claims
- 1243US12595292B2Interleukin-2 receptor (IL2R) and interleukin-2 (IL2) variants for specific activation of immune effector cellsBIONTECH CELL & GENE THERAPIES GMBH·Filed 2020·Granted Apr 7, 2026·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when SAHIN UGUR files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →